A non myeloablative regimen for allografting high-risk patients: Low toxicity, stable engraftment without GVHD, disease control and potential for GVL with adoptive immunotherapy.

A non myeloablative regimen for allografting high-risk patients: Low toxicity, stable engraftment without GVHD, disease control and potential for GVL with adoptive immunotherapy.

Bibliographic Details
Main Authors: Kottaridis, P, Chakraverty, R, Milligan, D, Chakrabarti, S, Robinson, S, Chopra, R, Pettengell, R, Marsh, J, Mahendra, P, Schey, S, Morgan, G, Williams, C, Hale, G, Waldmann, H, Linch, D, Devereux, S, Goldstone, A, Mackinnon, S
Format: Journal article
Published: 1999

Similar Items